BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 28666971)

  • 41. Osteoporosis and inflammation.
    Mundy GR
    Nutr Rev; 2007 Dec; 65(12 Pt 2):S147-51. PubMed ID: 18240539
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Role of the immune system in the pathophysiology of postmenopausal osteoporosis].
    Terauchi M
    Nihon Rinsho; 2011 Jul; 69(7):1215-9. PubMed ID: 21774360
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis.
    Pacifici R
    J Bone Miner Res; 1996 Aug; 11(8):1043-51. PubMed ID: 8854239
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased risk for bone loss in women with systemic sclerosis: a comparative study with rheumatoid arthritis.
    Kilic G; Kilic E; Akgul O; Ozgocmen S
    Int J Rheum Dis; 2016 Apr; 19(4):405-11. PubMed ID: 24283757
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ncf1 affects osteoclast formation but is not critical for postmenopausal bone loss.
    Stubelius A; Andersson A; Holmdahl R; Ohlsson C; Islander U; Carlsten H
    BMC Musculoskelet Disord; 2016 Nov; 17(1):464. PubMed ID: 27829407
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CCR6(+) Th cell populations distinguish ACPA positive from ACPA negative rheumatoid arthritis.
    Paulissen SM; van Hamburg JP; Davelaar N; Vroman H; Hazes JM; de Jong PH; Lubberts E
    Arthritis Res Ther; 2015 Nov; 17():344. PubMed ID: 26617177
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of the relative rates of bone mineral content loss in postmenopause due to both estrogen deficiency and ageing.
    Gnudi S; Mongiorgi R; Figus E; Bertocchi G
    Boll Soc Ital Biol Sper; 1990 Dec; 66(12):1153-9. PubMed ID: 2100526
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An increased concentration of receptor activator of nuclear factor kappa-B ligand pre-dates the onset of rheumatoid arthritis.
    Johansson L; Ärlestig L; Kokkonen H; Brink M; Rantapää-Dahlqvist S
    Rheumatology (Oxford); 2017 Dec; 56(12):2190-2196. PubMed ID: 29029341
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting.
    van Heemst J; Trouw LA; Nogueira L; van Steenbergen HW; van der Helm-van Mil AH; Allaart CF; Serre G; Holmdahl R; Huizinga TW; Toes RE; van der Woude D
    Arthritis Res Ther; 2015 Oct; 17():276. PubMed ID: 26437716
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ACPA (anti-citrullinated protein antibodies) and rheumatoid arthritis.
    Toes RE; van der Woude D
    Acta Reumatol Port; 2011; 36(3):205-7. PubMed ID: 22113596
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-citrullinated protein antibodies suppress let-7a expression in monocytes from patients with rheumatoid arthritis and facilitate the inflammatory responses in rheumatoid arthritis.
    Lai NS; Yu HC; Yu CL; Koo M; Huang HB; Lu MC
    Immunobiology; 2015 Dec; 220(12):1351-8. PubMed ID: 26227320
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structural changes and antibody enrichment in the lungs are early features of anti-citrullinated protein antibody-positive rheumatoid arthritis.
    Reynisdottir G; Karimi R; Joshua V; Olsen H; Hensvold AH; Harju A; Engström M; Grunewald J; Nyren S; Eklund A; Klareskog L; Sköld CM; Catrina AI
    Arthritis Rheumatol; 2014 Jan; 66(1):31-9. PubMed ID: 24449573
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies.
    Jiang X; Trouw LA; van Wesemael TJ; Shi J; Bengtsson C; Källberg H; Malmström V; Israelsson L; Hreggvidsdottir H; Verduijn W; Klareskog L; Alfredsson L; Huizinga TW; Toes RE; Lundberg K; van der Woude D
    Ann Rheum Dis; 2014 Oct; 73(10):1761-8. PubMed ID: 24812286
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Factors Associated with Erosive Arthritis in Rheumatoid Arthritis and Other Connective Tissue Diseases: A Retrospective Study From a Southern Chinese Population.
    Yuan S; Chen D; Xiao Y; Lao M; Qiu Q; Liang L; Yang X
    J Clin Rheumatol; 2016 Jan; 22(1):22-9. PubMed ID: 26693623
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The frequency of and risk factors for osteoporosis in Korean patients with rheumatoid arthritis.
    Lee JH; Sung YK; Choi CB; Cho SK; Bang SY; Choe JY; Hong SJ; Jun JB; Kim TH; Lee J; Lee HS; Yoo DH; Yoon BY; Bae SC
    BMC Musculoskelet Disord; 2016 Feb; 17():98. PubMed ID: 26912147
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Opposing effects of HLA-DRB1*13 alleles on the risk of developing anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis.
    Lundström E; Källberg H; Smolnikova M; Ding B; Rönnelid J; Alfredsson L; Klareskog L; Padyukov L
    Arthritis Rheum; 2009 Apr; 60(4):924-30. PubMed ID: 19333936
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibodies to porphyromonas gingivalis are associated with anticitrullinated protein antibodies in patients with rheumatoid arthritis and their relatives.
    Hitchon CA; Chandad F; Ferucci ED; Willemze A; Ioan-Facsinay A; van der Woude D; Markland J; Robinson D; Elias B; Newkirk M; Toes RM; Huizinga TW; El-Gabalawy HS
    J Rheumatol; 2010 Jun; 37(6):1105-12. PubMed ID: 20436074
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Siglec-15 is a potential therapeutic target for postmenopausal osteoporosis.
    Kameda Y; Takahata M; Mikuni S; Shimizu T; Hamano H; Angata T; Hatakeyama S; Kinjo M; Iwasaki N
    Bone; 2015 Feb; 71():217-26. PubMed ID: 25460183
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Do all anti-citrullinated protein/peptide antibody tests measure the same? Evaluation of discrepancy between anti-citrullinated protein/peptide antibody tests in patients with and without rheumatoid arthritis.
    Vander Cruyssen B; Nogueira L; Van Praet J; Deforce D; Elewaut D; Serre G; De Keyser F
    Ann Rheum Dis; 2008 Apr; 67(4):542-6. PubMed ID: 17644546
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protection against anti-citrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA-DRB1*1301: a meta-analysis of HLA-DRB1 associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in four European populations.
    van der Woude D; Lie BA; Lundström E; Balsa A; Feitsma AL; Houwing-Duistermaat JJ; Verduijn W; Nordang GB; Alfredsson L; Klareskog L; Pascual-Salcedo D; Gonzalez-Gay MA; Lopez-Nevot MA; Valero F; Roep BO; Huizinga TW; Kvien TK; Martín J; Padyukov L; de Vries RR; Toes RE
    Arthritis Rheum; 2010 May; 62(5):1236-45. PubMed ID: 20131291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.